Skip to Main Content


This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.

How Do I Listen?

HelixTalk is available via Apple Podcasts (or by searching for HelixTalk), by subscribing to our RSS feed, subscribing to our mailing list, or by listening to any episode in your browser (below).

Subscribe to Our Mailing List

HelixTalk Episodes

HelixTalk 162 - A1C You Later: A Concise Review of Continuous Glucose Monitors for the Practicing Pharmacist

Date posted: March 14, 2023, 6:00 am

In this first ever CE episode, we discuss the A-Zs of continuous glucose monitors (CGMs).

ACPE-Accredited Pharmacist CE (1.0 hrs)

To obtain CE credit for a $5 fee, visit the following link: Once payment is successful, you will be redirected to our CE partner (CE Impact) to complete an evaluation and to earn 1.0 hour of CE credit. CE is available for 12 months after episode publication.

HelixTalk #161 - My Loss Is Your Gain! How Drug Repository Programs Are Helping Patients Afford High-cost Medications

Date posted: February 21, 2023, 6:00 am

In this episode, we interview Dr. Shannon Rotolo and Dr. Alex Berce regarding Illinois and Wisconsin drug repository programs – these are programs that allow certain medications to be donated to participating sites and then redistributed to patients at a very low dispensing cost.

HelixTalk #160 - Dextromethorphan for Depression? Analyzing Data for Auvelity® in Major Depressive Disorder

Date posted: January 31, 2023, 6:00 am

In this episode, we discuss the evidence, safety, and place in therapy of Auvelity® (dextromethorphan-bupropion), a newly approved antidepressant with a unique mechanism of action and interesting pharmacokinetic considerations.

HelixTalk #159 - A Breath of Fresh Air: Big Changes to the 2023 GOLD Guidelines for COPD

Date posted: January 10, 2023, 6:00 am

In this episode, we highlight important changes to the 2023 GOLD Guidelines for COPD. In particular, we discuss a revision to the GOLD group classification system and the preferred initial therapies in patients with COPD.